Clinical Trials List
2024-10-31 - 2029-02-28
Phase II/III
Recruiting8
-
Trial Applicant
GEORGE CLINICAL ASIA PACIFIC LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Mu-Hsin Chang Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- 顏志傑 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- ZHENG-WEI ZHOU Division of Otolaryngology
- 劉時安 Division of Otolaryngology
- Cheng-Lun Lai 無
- 林天韻 Division of Otolaryngology
- 鄭皓升 Division of Otolaryngology
- 林玟君 Division of Otolaryngology
- 謝合原 Division of Otolaryngology
- YI-CHUN LIU Division of Otolaryngology
- CHENG-HSIEN LIN 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃彥霖 Division of Hematology & Oncology
- 王郁棻 Division of Hematology & Oncology
- HUAI-CHENG HUANG Division of Hematology & Oncology
- RUEY-LONG HONG Division of Hematology & Oncology
- 楊明翰 Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jeng-Shiun Du Division of Hematology & Oncology
- Hui-Hua Hsiao Division of Hematology & Oncology
- Shih-Feng Cho Division of Hematology & Oncology
- 謝子禹 Division of Hematology & Oncology
- 王閔宏 Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
- Yi-Chang Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 鄭小湘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
410 participants